Novel hydantoin derivatives for the treatment of obstructive airway diseases

Details for Australian Patent Application No. 2005260142 (hide)

Owner AstraZeneca AB

Inventors Ripa, Lena; Stenvall, Kristina; Gabos, Balint

Agent Freehills

Pub. Number AU-B-2005260142

PCT Pub. Number WO2006/004532

Priority 0401762-0 05.07.04 SE

Filing date 4 July 2005

Wipo publication date 12 January 2006

Acceptance publication date 28 August 2008

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/004532 Priority application(s): WO2006/004532

28 August 2008 Application Accepted

  Published as AU-B-2005260142

8 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005260143-Compounds

2005260140-Powder metallurgical composition comprising carbon black as flow enhancing agent